Evaluation Of 8-Hydroxy-2-Deoxyguanosine And Malondialdehyde Levels In First-Trimester Miscarriage: A Prospective Cohort Study

Year 2020, Volume: 47 Issue: 1, 74 - 81, 17.03.2020

Reyhan Gündüz Mete Gurol Ugur Neslihan Bayramoğlu Tepe Hüseyin Çağlayan Özcan Özcan Balat Sevgi Sari Demir Seyithan Taysi

https://doi.org/10.5798/dicletip.706022

Cited By: 2

Abstract

Objective: This study was aimed to evaluate 8-hydroxy-2-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) levels in patients with first trimester miscarriage.
Methods: This prospective cohort study included 35 women, who were diagnosed with miscarriage (patient group) and 35 healthy pregnant women below 14 weeks of gestation (control group), who did not report any complaints. 8-OHdG levels were measured with a competitive ELISA (Enzyme-Linked ImmunoSorbent Assay) high sensitivity kit and MDA levels were also measured in both groups.
Results: There wasn’t difference in terms of complete blood count, thyroid-stimulating hormone (TSH), homocysteine values, parity, age, body mass index (BMI) and gestational age between the groups. Serum 8-OHdG and MDA levels were significantly higher in the patient group (p=0.001). A moderate positive significant correlation between the gestational week and MDA values and a weak but significant positive correlation between 8-OHdG values and gestational week were detected in the patient group.
Conclusion: 8-OHdG and MDA could play a role in the etiopathogenesis of first-trimester miscarriage. However, this role must be further delineated in large-scaled studies for early diagnosis and management of this condition.

Keywords

Oxidative Stress, malondialdehyde, 8-hydroxy-2-deoxyguanosine, miscarriage

References

• 1. Cunningham FG, Leveno KJ, Bloom SL, et al. Williams Obstetrics, 24 th ed. NewYork: McGraw-Hill, 2014.
• 2. Simpson JL, Carson SA. Causes of fetal loss. In; Gray R, Leridon L, Spira F (eds). Symposium on Biological and Demographic Determinants of Human Reproduction. Oxford, Oxford University. 1993; 287.
• 3. Gergerlioglu HS, Savas HA, Bulbul F, et al. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. ProgNeuropsychopharmacolBiol Psychiatry. 2007; 31: 697-702.
• 4. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-biological interactions. 2006; 160: 1-40.
• 5. Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS. PREDICT-HD Investigators and Coordinators of the Huntington Study Group. 8OHdG as a marker for Huntington disease progression. Neurobiology of Disease. 2012; 625-34.
• 6. Kaçmaz A, Polat A, User Y, et al. Octreotide improves reperfusion-induced oxidative injury in acute abdominal hypertension in rats. J Gastrointest Surg. 2004; 113-9.
• 7. Okutan H, Savas C, Delibas N. The antioxidant effect of melatonin in lung injury after aortic occlusion-reperfusion. Interact CardiovascThorac Surg. 2004; 3: 519-22.
• 8. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem. 1997; 43: 1209-14.
• 9. Altuntaş H, Bayram F, Bitgen N, et al.Increased Chromosomal and Oxidative DNA Damage in Patients with Multinodular Goiter and Their Association with Cancer.Int J Endocrinol. 2017; Article ID 2907281.
• 10. Hunter MI, Nlemadim BC, Davidson DL. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res. 1985; 10: 1645-52.
• 11. Schorge JO, Schaffer JI, Halvorson LM, et al. Williams Gynecology, 2nd ed. NewYork: McGraw-Hill, 2010.
• 12. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management, and prognosis. Hum Reprod Update. 2002; 8: 463-81.
• 13. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988; 319: 189-94.
• 14. Maisonneuve E, Delvin E, Ouellet A, et al. Oxidative conditions prevail in severe IUGR with vascular disease and Doppler anomalies. J Matern Fetal Neonatal Med. 2015; 28: 1471-5.
• 15. Atiba AS, Abbiyesuku FM, Adekanle DA, et al. Malondialdehyde and antioxidant enzymes in second and third trimesters of pre-eclamptic Nigerian women. Niger Postgrad Med J. 2014; 21: 150-4.
• 16. Ferguson KK, McElrath TF, Chen YH, et al. Repeated measures of urinary oxidative stress biomarkers during pregnancy and preterm birth. Am J Obstet Gynecol. 2015; 212: 208.
• 17. Negi R, Pande D, Kumar A, Khanna RS, Khanna HD. In vivo oxidative DNA damage and lipid peroxidation as a biomarker of oxidative stress in preterm low-birthweight infants. J Trop Pediatr. 2012; 58: 326-8.
• 18. Qiu C, Hevner K, Abetew D, Enquobahrie DA, Williams MA. Oxidative DNA damage in early pregnancy and risk of gestational diabetes mellitus: A pilot study. Clinical biochemistry. 2011; 44: 804-8.
• 19. Peter Stein T, Scholl TO, Schluter MD, et al. Oxidative stress early in pregnancy and pregnancy outcome. Free radical research. 2008; 42: 841-8.
• 20. Mol BW, Lijmer JG, Ankum WM, Van der Veen F, Bossuyt PM. The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: a metaanalysis. Hum Reprod Nov. 1998; 13: 3220-7.
• 21. Onan A, Kurdoglu M, Sancak B, Bukan N, Yildirim M. Lipid peroxidation in nuchal cord cases: implication for fetal distress. J Matern Fetal Neonatal Med. 2009; 22: 254-8.
• 22. Singh AK, Pandey P, Tewari M, et al. Free radicals hasten head and neck cancer risk: A study of total oxidant, total antioxidant, DNA damage, and histological grade. J Postgrad Med. 2016; 62: 96–101.